全文获取类型
收费全文 | 172508篇 |
免费 | 16248篇 |
国内免费 | 8069篇 |
专业分类
耳鼻咽喉 | 2352篇 |
儿科学 | 3854篇 |
妇产科学 | 2002篇 |
基础医学 | 31964篇 |
口腔科学 | 5687篇 |
临床医学 | 13040篇 |
内科学 | 23149篇 |
皮肤病学 | 4494篇 |
神经病学 | 9504篇 |
特种医学 | 3762篇 |
外国民族医学 | 121篇 |
外科学 | 14908篇 |
综合类 | 26603篇 |
现状与发展 | 51篇 |
预防医学 | 4523篇 |
眼科学 | 4493篇 |
药学 | 13367篇 |
28篇 | |
中国医学 | 5165篇 |
肿瘤学 | 27758篇 |
出版年
2024年 | 303篇 |
2023年 | 2400篇 |
2022年 | 4010篇 |
2021年 | 6264篇 |
2020年 | 5539篇 |
2019年 | 5395篇 |
2018年 | 5566篇 |
2017年 | 5919篇 |
2016年 | 6215篇 |
2015年 | 7027篇 |
2014年 | 10187篇 |
2013年 | 11311篇 |
2012年 | 9773篇 |
2011年 | 10956篇 |
2010年 | 9121篇 |
2009年 | 8698篇 |
2008年 | 9249篇 |
2007年 | 9407篇 |
2006年 | 8554篇 |
2005年 | 7848篇 |
2004年 | 6963篇 |
2003年 | 6022篇 |
2002年 | 4944篇 |
2001年 | 4245篇 |
2000年 | 3508篇 |
1999年 | 3141篇 |
1998年 | 2992篇 |
1997年 | 2736篇 |
1996年 | 2436篇 |
1995年 | 2132篇 |
1994年 | 1869篇 |
1993年 | 1580篇 |
1992年 | 1267篇 |
1991年 | 1207篇 |
1990年 | 932篇 |
1989年 | 871篇 |
1988年 | 818篇 |
1987年 | 647篇 |
1986年 | 597篇 |
1985年 | 809篇 |
1984年 | 710篇 |
1983年 | 494篇 |
1982年 | 519篇 |
1981年 | 415篇 |
1980年 | 354篇 |
1979年 | 262篇 |
1978年 | 187篇 |
1977年 | 142篇 |
1976年 | 107篇 |
1975年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Azra Raza Harvey D. Preisler Ya Qin Li Richard A. Larson Jack Goldberg George Browman John Bennett Hans Grunwald Ralph Vogler Cathi Kukla 《American journal of hematology》1993,42(4):359-366
A pilot study was conducted of the biological characteristics of the leukemia cells of newly diagnosed patients with poor prognosis acute myelogenous leukemia (AML). This study included measurements of the pretherapy proliferative rate of the leukemia cells in vivo, assessment of differentiation in vivo during remission induction therapy, and the level of expression of the fms, myc, and IL1β genes in pretherapy leukemia cells. Short cell cycle times were characteristic of the best prognostic category and were associated with a rapid reduction in marrow leukemia cells in cytosine arabinoside (araC)-sensitive patients. Expression of c-fms was associated with rapid reduction in marrow leukemia cells during araC therapy and with a successful treatment outcome. Expression of the IL1β gene was associated with short remissions. These studies suggest that when compared to newly diagnosed standard prognosis AML, the leukemia of poor prognosis patients is more likely to exhibit long cell cycle times, low levels of fms expression, and is less likely to be associated with myeloid differentiation during remission induction therapy. © 1993 Wiley-Liss, Inc. 相似文献
992.
进一步研究了抗三尖杉酯碱的HL-60细胞(HR20)抗细胞凋亡的机制及该抗性和抗药性的关系。结果表明,环孢菌素A(CsA)20,10μg·ml ̄(-1)诱导HL-60细胞发生凋亡,而阻断HR20细胞于G_1期,就不能诱导细胞发生凋亡。低浓度的CsA明显增加柔红霉素在HR20细胞内的积聚,其逆转抗药性作用与阻断细胞周期运行无关。CsA10μg·ml ̄(-1)处理HR20细胞,可引起50kDa的蛋白质高度磷酸化。结果提示:环孢菌素A阻断抗三尖杉酯碱的HL-60细胞于G_1期,而诱导敏感的HL-60细胞发生凋亡,其阻断作用与抗药性无关 相似文献
993.
Peritoneal Desmoplastic Small Round Cell Tumors with Divergent Differentiation: A Review 总被引:2,自引:0,他引:2
E. J. Wills 《Ultrastructural pathology》1993,17(3):295-306
Peritoneal desmoplastic small round cell tumors with divergent differentiation are recently described highly aggressive neoplasms with characteristic clinical, morphologic, and immunohistochemical features. This review covers 38 cases that have been reported in the literature. The average age of patients is 18.4 years, and males are affected twice as frequently as females. Tumors generally present as multiple peritoneal nodules without obvious organ involvement. Histology shows islands of small cells set in dense desmoplastic stroma. Immunohistochemical stains are usually positive for cytokeratins, epithelial membrane antigen, desmin, and vimentin. Many cases also stain for neuron-specific enolase but rarely for other neuroepithelial markers. Ultrastructural appearances range from undifferentiated small cells to larger epithelial elements. Paranuclear aggregates of intermediate filaments are characteristic. Dense-core granules and other neuroendocrine features have been described in a minority of cases. Some tumors respond to chemotherapy, but most patients die within months to a few years. The histogenesis of these tumors is uncertain. 相似文献
994.
对127例IgA肾病(IgAN)患者和25例非IgA系膜增殖性肾炎血清进行了抗内皮细胞抗体AECA的检测。结果表明:IgA肾病患者和非IgA系膜增殖性肾炎患者血清AECA-IgG较正常对照组高,而IgAN患者较非IgA系膜增殖性肾炎患者AECA-IgG的水平高,P〈0.05。IgAN患者的AECA-IgA水平较正常对照组高。IgAN患者按AECA水平分为阳性与阴性组,对两组硬化面积比进行比较,未见 相似文献
995.
M. Brugiatelli B. Jaksic A. Planinc-Peraica R. Kusec S. Ostojic V. Callea P. Lacopino F. Morabito C. Stelitano D. Lutz 《European journal of haematology》1995,55(3):158-163
Abstract: In 1982 the IGCI CLL cooperative group decided to investigate the usefulness of treating, at diagnosis B-cell chronic lymphocytic leukemia (CLL) in early and stable phase of the disease. From January 1982 to December 1986, 148 patients were randomized either to receive immediate treatment with chlorambucil (CLB) or to defer therapy to the time of progression. The early and stable phase of the disease was defined by a total tumor mass (TTM) score < 9, the absence of anemia or thrombocytopenia and a doubling time > 12 months. The main end-point of the study was survival. At the last evaluation in April 1993, after a median follow-up of 75 months, no significant difference was found in overall survival between early vs. deferred treatment patients from every cause of death as well as from death due to CLL-related causes only. The same results were obtained when the patients in more favorable stages, such as Binet stage A and TTM < 4.5, were considered. Interestingly, the incidence of epithelial cancer was similar in the two groups. Early treatment was associated with a significantly better response and a lower progression rate. From this long-term experience, it can be concluded that immediate chemotherapy with CLB is not beneficial for CLL patients in early and stable phase of the disease in terms of survival. 相似文献
996.
997.
The performance of the CELL-DYN 1700® (Abbott Diagnostics, Abbott Park, IL, USA) was evaluated in a tertiary care hospital laboratory using the guidelines proposed by the German Society of Clinical Chemistry. Precision, accuracy, linearity, background counts, and carry-over were satisfactory for all measured standard parameters including haemoglobin concentration, haematocrit, red blood cell count, mean corpuscular volume (MCV), red cell distribution width (RDW), white blood cell count and platelet count. With 259 selected normal and abnormal blood samples the results of the CELL-DYN 1700® (CD1700) compared very well (r > 0.96 for all parameters with exception of RDW) with those obtained with the Bayer Diagnostic H-1 and the Hoffmann-La Roche Cobas Argos systems. This study considered in particular the performance of the CD1700 three-part leucocyte differential. For those samples without instrument-generated suspect flags, the neutrophil and lymphocyte percentages were highly correlated with the results of the H-1 blood cell counter (r = 0.97 and 0.98, respectively) and with manual 400-cell differentials (r = 0.91 and 0.88, respectively). In contrast, the CD1700 mid-fraction which comprised the composite total of mono cytes, eosinophils, basophils and precursor white cells (when present) could not be directly compared to the differentials from the H-1 system or from manual microscopy. For those samples with CD1700 instrument suspect flags, the neutrophil and lymphocyte differential results also compared well with both the H-1 (r = 0.93 and 0.93, respectively) and manual estimates (r = 0.89 and 0.87, respectively). In conclusion, the CD1700 is an accurate haematology analyser for cellular blood counts and three-part leucocyte differentiation. 相似文献
998.
Neuropathology in non-human immunodeficiency virus-infected drug addicts: hypoxic brain damage after chronic intravenous drug abuse 总被引:3,自引:0,他引:3
Neuropathological studies were carried out on 180 human immunodeficiency virus-seronegative intravenous drug addicts. The
findings in victims of acute heroin intoxication (n = 116) were congestion (99.1%), capillary engorgement (68.1%), and/or perivascular bleeding (68.1%) – hemodynamic processes
attributable to toxic primary respiratory failure. In a high percentage of these cases (88%), cerebral edema was also present.
In 18 cases of acute heroin intoxication who survived for periods of hours or days, the sole postmortem finding was ischemic
nerve cell damage, resembling that typically seen in systemic hypoxia. Semiquantitative analysis revealed nerve cell loss
in the hippocampal formation and/ or Purkinje cell layer in 26% of the 162 chronic drug abusers. By contrast, in nearly 80%
of these cases, the hippocampus showed enhanced expression of glial fibrillary acid protein by astrocytes and/or a proliferation
of microglia, demonstrated by CD68 expression. Since such reactive processes are produced by primary neuronal damage, it can
be assumed that chronic intravenous drug abuse results in obviously ischemic nerve cell loss. This could be demonstrated in
the hippocampus, but it must also occur throughout the whole brain. The demonstration of ischemic nerve cell damage and neuronal
loss or secondary reactive alterations has not been described previously.
Received: 31 March 1995 / Revised, accepted: 27 November 1995 相似文献
999.
肾病患儿免疫细胞对肾小球上皮细胞合成基质的影响 总被引:1,自引:0,他引:1
目的为了明确免疫细胞对肾小球上皮细胞(glomerularepithelialcelGEC)合成功能的直接作用。方法应用肾小球细胞体外培养,同位素掺入及放射免疫技术,以总胶原,层粘连蛋白,Ⅲ型前胶原及Ⅳ型胶原的合成为观察指标,动态研究了不同病理类型原发性肾病综合征(INS)患儿外周血单个核细胞(peripheralbloodmononuclearcelPBMC)对GEC生物功能的影响。结果(1)肾病极期未经激素治疗组(未治组)PBMC上清明显促进了GEC合成层粘连蛋白;(2)未治PBMC上清抑制了GEC合成总胶原;(3)未治组PBMC上清促进了Ⅲ型前胶原的合成,而对Ⅳ型胶原的合成无明显影响;(4)肾病患儿PBMC的上述作用与是否足量激素治疗有关,而与尿蛋白能否阴转、肾组织病理类型、肾病临床类型等无直线相关关系。结论原发性肾病患儿循环免疫细胞可影响GEC合成细胞外基质的功能。免疫细胞的这种活性可被激素治疗改变。 相似文献
1000.
T. Ishikawa T. Yagi H. Sadamori N. Ishine H. Sasaki M. Oishi N. Tanaka 《Transplant international》1998,11(S1):S410-S416
Abstract This study was designed to investigate the effects of differences in the route of nutritional support of the donor on cold ischemia/reperfusion injury. Participation of Kupffer cells in these effects, based on the analysis of hepatic energy metabolism in early phases of reperfusion was also investigated. Orthotopic liver transplantation was performed between Large-White pigs weighing 20–30 kg after a 4-h cold preservation of the graft in Euro-Collins solution at 4°C. One group was fed orally with a standard laboratory diet (FED group, n = 5), a second group was fasted and given 20% glucose intravenously (12 kJ/kg per day) (PEF group, n = 5), and a third group was fed orally with a standard laboratory diet and given GdCI3 (10 mg/kg) intravenously 24 h before operation (FEDGD group, n = 5). These treatments were given for 7 days prior to harvesting. The survival time was significantly longer in the PEF (34.8 ± 5.5 days) and FEDGD (28.0 ± 11.9 days) groups than in the FED (9.8 ± 2.0 days) group ( P < 0.05). The serum hyaluronic acid elimination rate determined from 1 to 2 h after reperfusion was significantly lower in the FED group than in the other two groups ( P < 0.001). The glycogen content of the livers 1 h after reperfusion in all three groups had been consumed rapidly, but the ATP content of the livers was significantly reduced in the FED group alone ( P < 0.01). Hepatic FFA clearance (CFFA ) was moderately increased in all three groups in the early phase after reperfusion, but it was higher in the FED group than in the other two groups, with significant differences 1 and 2 h after reperfusion ( P < 0.05). In conclusion, parenteral nutrition of the donors reduced cold ischemia/reperfusion injury which is related to Kupffer cell activation and, thus, was better than enteral nutrition for donor management. 相似文献